School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Boston, MA, USA.
Department of Neurosurgery, Santa Croce e Carle Hospital, Cuneo, Italy.
Acta Neurochir (Wien). 2022 Dec;164(12):3221-3233. doi: 10.1007/s00701-022-05338-z. Epub 2022 Aug 13.
Surgery and radiosurgery represent the most common treatment options for vestibular schwannoma. A systematic review and meta-analysis were conducted to compare the outcomes of surgery versus stereotactic radiosurgery (SRS).
The Cochrane library, PubMed, Embase, and clinicaltrials.gov were searched through 01/2021 to find all studies on surgical and stereotactic procedures performed to treat vestibular schwannoma. Using a random-effects model, pooled odds ratios (OR) and their 95% confidence intervals (CI) comparing post- to pre-intervention were derived for pre-post studies, and pooled incidence of adverse events post-intervention were calculated for case series and stratified by intervention type.
Twenty-one studies (18 pre-post design; three case series) with 987 patients were included in the final analysis. Comparing post- to pre-intervention, both surgery (OR: 3.52, 95%CI 2.13, 5.81) and SRS (OR: 3.30, 95%CI 1.39, 7.80) resulted in greater odds of hearing loss, lower odds of dizziness (surgery OR: 0.10; 95%CI 0.02, 0.47 vs. SRS OR: 0.22; 95%CI 0.05, 0.99), and tinnitus (surgery OR: 0.23; 95%CI 0.00, 37.9; two studies vs. SRS OR: 0.11; 95%CI 0.01, 1.07; one study). Pooled incidence of facial symmetry loss was larger post-surgery (14.3%, 95%CI 6.8%, 22.7%) than post-SRS (7%, 95%CI 1%, 36%). Tumor control was larger in the surgery (94%, 95%CI 83%, 98%) than the SRS group (80%, 95%CI 31%, 97%) for small-to-medium size tumors.
Both surgery and SRS resulted in similar odds of hearing loss and similar improvements in dizziness and tinnitus among patients with vestibular schwannoma; however, facial symmetry loss appeared higher post-surgery.
手术和放射外科是治疗前庭神经鞘瘤最常见的治疗选择。我们进行了一项系统评价和荟萃分析,以比较手术与立体定向放射外科(SRS)的结果。
通过 Cochrane 图书馆、PubMed、Embase 和 clinicaltrials.gov 对 2021 年 01 月之前发表的所有关于手术和立体定向治疗前庭神经鞘瘤的研究进行了检索。对于前后研究,使用随机效应模型得出了术后与术前比较的合并优势比(OR)及其 95%置信区间(CI),对于病例系列研究,按干预类型分层计算了术后不良事件的发生率。
最终分析纳入了 21 项研究(18 项前后设计;3 项病例系列研究)共 987 例患者。与术前相比,手术(OR:3.52,95%CI 2.13,5.81)和 SRS(OR:3.30,95%CI 1.39,7.80)均导致听力损失的可能性更大,头晕(手术 OR:0.10;95%CI 0.02,0.47 与 SRS OR:0.22;95%CI 0.05,0.99)和耳鸣(手术 OR:0.23;95%CI 0.00,37.9;两项研究与 SRS OR:0.11;95%CI 0.01,1.07;一项研究)的可能性更低。术后面部对称性丧失的发生率在手术组(14.3%,95%CI 6.8%,22.7%)高于 SRS 组(7%,95%CI 1%,36%)。对于小到中等大小的肿瘤,手术组的肿瘤控制率(94%,95%CI 83%,98%)高于 SRS 组(80%,95%CI 31%,97%)。
手术和 SRS 治疗前庭神经鞘瘤患者的听力损失几率相似,头晕和耳鸣的改善情况也相似;然而,手术后面部对称性丧失的发生率更高。